Ingenuity Technology Licensed by SPRI
News Oct 13, 2005
Ingenuity has announced that Schering-Plough Research Institute has licensed both Ingenuity Pathways Analysis and the Ingenuity Pathways Analysis Integration Module (IPA-IM).
Ingenuity Pathways Analysis 3.0 (IPA) is designed to enable biologists and bioinformaticians to model, analyze, and understand the complex biological systems at the core of all life science research.
Ingenuity claims that, IPA leverages the world largest and highest quality knowledge base of biological networks and powerful algorithms, along with a software interface, to provide researchers with the insights and confidence needed to make better and faster decisions at every step of their research.
With access to the release of Ingenuity Pathways Analysis 3.0, scientists will now be able to integrate their own biological relationships with Ingenuity pathways to create custom networks for particular targets, biomarkers, disease areas, and processes and enable powerful computation and functional analysis.
Researchers will also benefit from Ingenuity Pathways Analysis 3.0's vastly expanded search capabilities and a doubling of the gene and disease content.
Bioethics Council Rules Heritable Genome Editing "Ethically Acceptable" In Certain CircumstancesNews
A leading UK bioethics advisory body has weighed in on the debate around human genetic modification, concluding that heritable genome editing – modifying the DNA of an egg, sperm or embryo with changes that will be passed on to future generations – could be ‘morally permissible’ in humans, provided key ethical tests are met.
Genetic Factors Leading to Rare Bone Fusion Disorder IdentifiedNews
Genome sequencing establishes multiple genes responsible for a rare condition that cause bone fusionREAD MORE
Hay Fever Risk Genes Overlap with Autoimmune DiseaseNews
In a large international study involving almost 900,000 participants, researchers from the University of Copenhagen and COPSAC have found new risk genes for hay fever. It is the largest genetic study so far on this type of allergy, which affects millions of people around the world.READ MORE